Skip to main content
SkinCited

Nicotinamide 관련 자외선 방어(내적 광보호)

A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.

At chemoprevention doses (1,000 mg/day), oral nicotinamide replenishes UV-depleted NAD+ stores, enhancing cellular energy for DNA repair and supporting immune surveillance of UV-damaged cells (ONTRAC Phase 3 trial).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dnicotinamide\u0026condition\u003Duv\u002Dprotection'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            A

        

        

            
결론

            
            
At chemoprevention doses (1,000 mg/day), oral nicotinamide replenishes UV-depleted NAD+ stores, enhancing cellular energy for DNA repair and supporting immune surveillance of UV-damaged cells (ONTRAC Phase 3 trial).

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Review
                
                
                
                
            

            
                The adverse effects of oral niacin/nicotinamide - an overview of reviews.
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: None
                
                
                효과: None
                
                
                None
                
            

            
            
대상 집단: Overview of reviews on niacin/nicotinamide adverse effects

            
        

        
        

            

                
                    Meta-Analysis
                
                
                
                
            

            
                The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.
            
            

                
                Dose: Nicotinamide (vitamin B3)
                
                
                vs: Placebo
                
                
                Outcome: AK and NMSC incidence reduction
                
                
                효과: None
                
                
                None
                
            

            
            
대상 집단: High-risk NMSC patients (RCTs)

            
        

        
        

            

                
                    Review
                
                
                
                
            

            
                Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, …
            
            

                
                Dose: None
                
                
                vs: Placebo
                
                
                
                효과: None
                
                
                None
                
            

            
        

        
        

            

                
                    Other
                
                
                
                
            

            
                Nicotinamide: An Update and Review of Safety & Differences from Niacin.
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: None
                
                
                효과: None
                
                
                None
                
            

            
            
대상 집단: None

            
        

        
        

            

                
                    Review
                
                
                
                
            

            
                Final report of the safety assessment of niacinamide and niacin.
            
            

                
                Dose: Niacinamide up to 5%; Niacin up to 0.1%
                
                
                vs: None
                
                
                Outcome: Safety assessment for cosmetic use
                
                
                효과: Safe as used in cosmetics
                
                
                None
                
            

            
            
대상 집단: General population (cosmetic users)

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
5

        
연구

    

    

        
686

        
참여자

    

    

        
            
            ↑
            
        
        
Positive

    

    

        A

        
등급

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            The adverse effects of oral niacin/nicotinamide - an overview of reviews.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        Eye (London, England)
                        2025
                        
                        1 인용
                        
                    

                

                
                

                    

                        
                            The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.
                        
                        
                            
                                Meta-Analysis
                            
                            
                            
                        
                    

                    

                        Nutrients
                        2023
                        
                        16 인용
                        
                    

                

                
                

                    

                        
                            Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        Journal of the …
                        2021
                        
                        46 인용
                        
                    

                

                
                

                    

                        
                            Nicotinamide: An Update and Review of Safety & Differences from Niacin.
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        Skin therapy letter
                        2020
                        
                        13 인용
                        
                    

                

                
                

                    

                        
                            Final report of the safety assessment of niacinamide and niacin.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        International journal of …
                        2005
                        
                        22 인용
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
일반적으로 사용되는 용량

                

                    
                    

                        
generalskinbarrier:

                        
500-1,500 mg/day

                    

                    
                    

                        
skincancerchemoprevention:

                        
500 mg twice daily (1,000 mg/day total)

                    

                    
                

                
                

                    상한량: Generally well-tolerated up to 3,000 mg/day (no flushing unlike niacin)
                

                
            

            

            
            

                
연구에서 사용된 용량

                

                    

                        
                            

                                용량
                                기간
                                효과
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                            

                                Nicotinamide (vitamin B3)
                                --
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                            

                                None
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                            

                                None
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                            

                                Niacinamide up to 5%; Niacin up to 0.1%
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                권장 복용 시간: With meals; split into 2 doses for chemoprevention
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
보고된 부작용

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated (no flushing)
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort at high doses
                        
    • 
                        
                        
  • 
                            ⚠
                            Rare hepatotoxicity at very high doses
                        
    • 
                        
                    

                

                

                
                

                    
알려진 상호작용

                    
    
                        
                        
  • 
                            ●
                            Anticonvulsants (carbamazepine — may increase levels)
                        
    • 
                        
                        
  • 
                            ●
                            Isoniazid (competes for NAD+ pathways)
                        
    • 
                        
                        
  • 
                            ●
                            Hepatotoxic drugs (potential additive liver effect at high doses)
                        
    • 
                        
                    

                

                

                
                

                    

                        일일 최대 섭취 허용량: Generally well-tolerated up to 3,000 mg/day (no flushing unlike niacin)
                    

                

                
            

            

                건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Nicotinamide help with 자외선 방어(내적 광보호)?
            
        
        

            Based on 5 studies with 686 participants, there is strong evidence from multiple clinical trials that Nicotinamide may support 자외선 방어(내적 광보호) management. Our evidence grade is A (Strong Evidence).
        

    

    
    

        
            How much Nicotinamide should I take for 자외선 방어(내적 광보호)?
            
        
        

            Studies have used various dosages. A commonly studied range is 500-1,500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Nicotinamide?
            
        
        

            Reported side effects may include Generally well-tolerated (no flushing), Mild gastrointestinal discomfort at high doses, Rare hepatotoxicity at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Nicotinamide and 자외선 방어(내적 광보호)?
            
        
        

            We rate the evidence as Grade A (Strong Evidence). This rating is based on 5 peer-reviewed studies with 686 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                
                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Su Ling Young et al..
      Eye (Lond).
      2025.
      The adverse effects of oral niacin/nicotinamide - an overview of reviews.
      doi:10.1038/s41433-025-04027-2
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Giulio Tosti et al..
      Nutrients.
      2023.
      The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.
      doi:10.3390/nu16010100
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Katherine G Thompson et al..
      J Am Acad Dermatol.
      2021.
      Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium.
      doi:10.1016/j.jaad.2020.04.123
      PubMed
    
    4. 
    
    
  4. 
      [4]
      Reed Huber et al..
      Skin Therapy Lett.
      2020.
      Nicotinamide: An Update and Review of Safety & Differences from Niacin.
      
      PubMed
    
    5. 
    
    
  5. 
      [5]
      Cosmetic Ingredient Review Expert Panel.
      Int J Toxicol.
      2005.
      Final report of the safety assessment of niacinamide and niacin.
      doi:10.1080/10915810500434183
      PubMed
    
    6. 
    
  















    

        FDA 면책 조항:
        이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.